Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Cell Biology

Total Results:

14178


New specimens of Stirtonia from the La Victoria Formation, La Venta, Colombia and the evolution of alouattin dental and mandibular form [Meeting Abstract]

Cooke, Siobhan B.; Felipe Vanegas, Andres; Link, Andres; Shearer, Brian M.; Stroik, Laura K.; Tallman, Melissa
ISI:000423063102186
ISSN: 0002-9483
CID: 4141132

Amyloid beta oligomerization negatively influences brain clearance mechanisms [Meeting Abstract]

Rostagno, A; Giannoni, P; McIntee, F; Cabrera, E; Neubert, T; Ghiso, J
Aims Several lines of investigation support the notion that synaptic pathology, one of the strongest correlates to cognitive impairment, is related to progressive accumulation of neurotoxic amyloid beta (Abeta) oligomers. Since the process of oligomerization/fibrillization is concentration-dependent, it is highly reliant on the homeostatic mechanisms that regulate the steady state levels of Abeta influencing the delicate balance between rate of synthesis, dynamics of aggregation and clearance kinetics. Emerging new data suggest that reduced Abeta clearance, particularly in the aging brain, plays a critical role in the process of amyloid formation and AD pathogenesis. Method We have used a combination of stereotaxic injection into the hippocampal region of C57BL/6 wild-type mice with biochemical and mass spectrometric analyses of CSF to evaluate the brain clearance and catabolism of well-defined monomeric and low molecular mass Abeta oligomeric assemblies. Results Abeta physiologic removal from the brain is extremely fast, involves local proteolytic degradation with generation of heterogeneous C-terminally cleaved proteolytic products, and is negatively influenced by oligomerization. Immunofluorescence confocal microscopy studies provide insight into the cellular pathways involved in the brain removal and cellular uptake of Abeta. Clearance from brain interstitial fluid follows local and systemic paths; in addition to the BBB, local enzymatic degradation and transport through the choroid plexus into the CSF play significant roles. Conclusion Our studies highlight the diverse factors influencing brain clearance and the participation of various routes of elimination opening up new research opportunities for the understanding of altered mechanisms triggering AD pathology and for the potential design of combined therapeutic strategies
EMBASE:615511586
ISSN: 1660-2862
CID: 2553652

Correction: Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography [Correction]

Kripke, Katharine; Chimbwandira, Frank; Mwandi, Zebedee; Matchere, Faustin; Schnure, Melissa; Reed, Jason; Castor, Delivette; Sgaier, Sema; Njeuhmeli, Emmanuel
[This corrects the article DOI: 10.1371/journal.pone.0156521.].
PMCID:5207517
PMID: 28046115
ISSN: 1932-6203
CID: 2439792

A Robust Text Classifier Based on Denoising Deep Neural Network in the Analysis of Big Data

Aziguli, W; Hang, Y; Xie, Y; Zhang, D; Luo, X; Li, C; Zhang, Y
Text classification has always been an interesting issue in the research area of natural language processing (NLP). While entering the era of big data, a good text classifier is critical to achieving NLP for scientific big data analytics. With the ever-increasing size of text data, it has posed important challenges in developing effective algorithm for text classification. Given the success of deep neural network (DNN) in analyzing big data, this article proposes a novel text classifier using DNN, in an effort to improve the computational performance of addressing big text data with hybrid outliers. Specifically, through the use of denoising autoencoder (DAE) and restricted Boltzmann machine (RBM), our proposed method, named denoising deep neural network (DDNN), is able to achieve significant improvement with better performance of antinoise and feature extraction, compared to the traditional text classification algorithms. The simulations on benchmark datasets verify the effectiveness and robustness of our proposed text classifier
SCOPUS:85042745445
ISSN: 1058-9244
CID: 3223532

The first case of recurrent ultra late onset group B streptococcal sepsis in a 3-year-old child

Hosoda, Ai; Gatayama, Ryohei; Moriyama, Shiori; Ishii, Noriyuki; Yamada, Kenichiro; Matsuzaki, Youhei; Shinjoh, Masayoshi
Group B streptococcus (GBS) is a commonly recognized cause of sepsis and meningitis in neonatal and young infants. Invasive GBS infection is classified into early onset GBS disease (EOD, day 0-6), late onset GBS disease (LOD, day 7-89) and ultra late onset GBS disease (ULOD, after 3 months of age). ULOD is uncommon and recurrence is especially rare. We present the first recurrent case of ULOD GBS sepsis in 3-year-old girl with a past medical history of hydrops fetalis and thoracic congenital lymphatic dysplasia. The first episode presented as sepsis at 2 years 8 months of age. The second episode occurred as sepsis with encephalopathy at 3 years 1 months of age. During each episode, the patient was treated using intravenous antimicrobials and her condition improved. Serotype examination was not performed in the first episode, but GBS type V was serotyped in the second episode. ULOD over 1 year of age is quite rare and may recur.
PMCID:5133645
PMID: 27920985
ISSN: 2214-2509
CID: 3094912

Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer

Dai, Liping; Li, Jitian; Tsay, Jun-Chieh J; Yie, Ting-An; Munger, John S; Pass, Harvey; Rom, William N; Tan, Eng M; Zhang, Jian-Ying
Identification of biomarkers for early detection of lung cancer (LC) is important, in turn leading to more effective treatment and reduction of mortality. Serological proteome analysis (SERPA) was used to identify proteins around 34 kD as ECH1 and HNRNPA2B1, which had been recognized by serum autoantibody from 25 LC patients. In the validation study, including 90 sera from LC patients and 89 sera from normal individuals, autoantibody to ECH1 achieved an area under the curve (AUC) of 0.799 with sensitivity of 62.2% and specificity of 95.5% in discriminating LC from normal individuals, and showed negative correlation with tumor size (rs = -0.256, p = 0.023). Autoantibody to HNRNPA2B1 performed an AUC of 0.874 with sensitivity of 72.2% and specificity of 95.5%, and showed negative correlation with lymph node metastasis (rs = -0.279, p = 0.012). By using longitudinal preclinical samples, autoantibody to ECH1 showed an AUC of 0.763 with sensitivity of 60.0% and specificity of 89.3% in distinguishing early stage LC from matched normal controls, and elevated autoantibody levels could be detected greater than 2 y before LC diagnosis. ECH1 and HNRNPA2B1 are autoantigens that elicit autoimmune responses in LC and their autoantibody can be the potential biomarkers for the early detection of LC.
PMCID:5467997
PMID: 28638733
ISSN: 2162-4011
CID: 2604012

GroEL and the GroEL-GroES Complex

Ishii, Noriyuki
Chaperonin is categorized as a molecular chaperone and mediates the formation of the native conformation of proteins by first preventing folding during synthesis or membrane translocation and subsequently by mediating the step-wise ATP-dependent release that result in proper folding. In the GroEL-GroES complex, a single heptameric GroEL ring binds one GroES ring in the presence of ATP/ADP, in this vein, the double ring GroEL tetradecamer is present in two distinct types of GroEL-GroES complexes: asymmetric 1:1 "bullet"-shaped GroEL:GroES and symmetric 1:2 "football" (American football)-shaped GroEL:GroES2. There have been debates as to which complex is critical to the productive protein folding mediated by the GroEL-GroES complex, and how GroES coordinates with GroEL in the chaperonin reaction cycle in association with regulation by adenine nucleotides and through the interplay of substrate proteins. A lot of knowledge on chaperonins has been accumulating as if expanding as ripples spread around the GroEL-GroES from Escherichia coli. In this article, an overview is presented on GroEL and the GroEL-GroES complex, with emphasis on their morphological variations, and some potential applications to the fabrication of nanocomposites using GroEL as a nano-block. In parallel, a guideline is presented that supports the recognition that the E. coli and its GroEL-GroES complex do not always receive in standard literature because the biochemical features of chaperonins derived from others special, such as mammals, are not always the same as those confirmed using GroEL-GroES derived from E. coli.
PMID: 28271487
ISSN: 0306-0225
CID: 3079732

A Patient with Cystic Granuloma Trichophyticum who Required Surgical Resection [Case Report]

Kaneko, Takehiko; Kaneko, Michiyo
A 62-year-old male with numerous subcutaneous nodules in the lower extremities was referred to The University of Tokyo Hospital. The patient suffered from systemic lupus erythematosus (SLE), diabetes mellitus, and persisting hepatic dysfunction, and had been treated for SLE with oral prednisolone 20 mg/day and oral cyclosporine 3 mg/kg/day. The culture of scales collected from the patient's skin surface on Sabouraud's dextrose agar medium showed features of Trichophyton rubrum. Topically applied bifonazole cream was effective for tinea corporis, but oral griseofulvin 500 mg/day was discontinued after 2-month administration because of deteriorated liver function. All the nodules were resected surgically. Histologically, resected granulomas showed dermal abscesses that were tightly encapsulated by fibrous capsules. Grocott staining revealed numerous fungal elements within abscesses. The patient's condition indicated the need to perform histopathological examination of granuloma trichophyticum in order to determine whether it is tightly encapsulated. Namely, the presence of cystic granuloma trichophyticum with abscesses encapsulated by fibrous capsules suggested that the patient should be treated by surgical resection of the lesions.
PMID: 28250361
ISSN: 1882-0476
CID: 3079282

The Emerging Role for Zinc in Depression and Psychosis

Petrilli, Matthew A; Kranz, Thorsten M; Kleinhaus, Karine; Joe, Peter; Getz, Mara; Johnson, Porsha; Chao, Moses V; Malaspina, Dolores
Zinc participation is essential for all physiological systems, including neural functioning, where it participates in a myriad of cellular processes. Converging clinical, molecular, and genetic discoveries illuminate key roles for zinc homeostasis in association with clinical depression and psychosis which are not yet well appreciated at the clinical interface. Intracellular deficiency may arise from low circulating zinc levels due to dietary insufficiency, or impaired absorption from aging or medical conditions, including alcoholism. A host of medications commonly administered to psychiatric patients, including anticonvulsants, oral medications for diabetes, hormones, antacids, anti-inflammatories and others also impact zinc absorption. Furthermore, inefficient genetic variants in zinc transporter molecules that transport the ion across cellular membranes impede its action even when circulating zinc concentrations is in the normal range. Well powered clinical studies have shown beneficial effects of supplemental zinc in depression and it important to pursue research using zinc as a potential therapeutic option for psychosis as well. Meta-analyses support the adjunctive use of zinc in major depression and a single study now supports zinc for psychotic symptoms. This manuscript reviews the biochemistry and bench top evidence on putative molecular mechanisms of zinc as a psychiatric treatment.
PMCID:5492454
PMID: 28713269
ISSN: 1663-9812
CID: 2908992

A wild-type mouse-based model for the regression of inflammation in atherosclerosis

Peled, Michael; Nishi, Hitoo; Weinstock, Ada; Barrett, Tessa J; Zhou, Felix; Quezada, Alexandra; Fisher, Edward A
Atherosclerosis can be induced by the injection of a gain-of-function mutant of proprotein convertase subtilisin/kexin type 9 (PCSK9)-encoding adeno-associated viral vector (AAVmPCSK9), avoiding the need for knockout mice models, such as low-density lipoprotein receptor deficient mice. As regression of atherosclerosis is a crucial therapeutic goal, we aimed to establish a regression model based on AAVmPCSK9, which will eliminate the need for germ-line genetic modifications. C57BL6/J mice were injected with AAVmPCSK9 and were fed with Western diet for 16 weeks, followed by reversal of hyperlipidemia by a diet switch to chow and treatment with a microsomal triglyceride transfer protein inhibitor (MTPi). Sixteen weeks following AAVmPCSK9 injection, mice had advanced atherosclerotic lesions in the aortic root. Surprisingly, diet switch to chow alone reversed hyperlipidemia to near normal levels, and the addition of MTPi completely normalized hyperlipidemia. A six week reversal of hyperlipidemia, either by diet switch alone or by diet switch and MTPi treatment, was accompanied by regression of atherosclerosis as defined by a significant decrease of macrophages in the atherosclerotic plaques, compared to baseline. Thus, we have established an atherosclerosis regression model that is independent of the genetic background.
PMCID:5349694
PMID: 28291840
ISSN: 1932-6203
CID: 2488542